Skip to main content

University of California San Francisco

UCSF |

About UCSF | Search UCSF

Technology Disclosure

Services
Teams
Resources
About
Media
- News
- Newsletters
- Podcasts
- Videos

linkedin
vimeo
youtube

Skip to main content

Home

Therapeutics

Available Technologies

153 Therapeutics

153 Therapeutics

AMT

Adipose Manipulation Transplantation, A Novel Cancer Therapy

AER Therapeutics

153 Therapeutics

Alessa

Adipose Manipulation Transplantation, A Novel Cancer Therapy

Novel Therapeutic

A novel therapeutically druggable target to reverse aging

Unamed Therapeutic

Cell Surface Restricted ß1 Blocker for Diastolic Dysfunction

Ceiba Bio

Cell Surface Restricted ß1 Blocker for Diastolic Dysfunction

En-Cell-In

En-Cell-In Redefining cell therapy for safe, scalable, immune-protected medicine.

About
Teams
Services
Partnerships
Resources

RECENT NEWS

UCSF Receives $824M in NIH Funding, Driving Medical Breakthroughs
Molecular Garbage on Tumors Makes Easy Target for Antibody Drugs
VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis

Contact

Email: [email protected]
UCSF Wayne and Gladys Valley Center
490 Illinois Street, North Tower, 400-A
San Francisco, CA 94143
Campus Mail: PO box: 2142

linkedin
vimeo
youtube

2026 © The Regents of the University of California

Accessibility
Usage
Privacy